Global Endowment Management, LP Gilead Sciences, Inc. Transaction History

Global Endowment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $1.63 Million - $1.8 Million	-26,100 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $2.34 Million - $2.63 Million	-37,900 Reduced 59.22%	26,100 $1.76 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $4 Million - $4.48 Million	64,000 New	64,000 $4.16 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $5.28 Million - $6.89 Million	-87,200 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $6.22 Million - $6.88 Million	87,200 New	87,200 $6.73 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $3.51 Million - $4.28 Million	-48,200 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $3.43 Million - $4.03 Million	48,200	48,200 $3.45 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Global Endowment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Global Endowment Management, LP with notifications on news.